UK-based specialist healthcare company BTG plc
(LSE: BTG) has received 510k clearance from the US Food and Drug Administration for LC Bead LUMI, the first commercially available radiopaque embolic bead for the embolisation of hypervascular tumors and arteriovenous malformations, the company said on Monday.
8 January 2015 - UK-based specialist healthcare company BTG plc
(LSE: BTG) has closed its acquisition of US-based pulmonology business PneumRx Inc, the company said on Thursday.
M2 EQUITYBITES-May 6, 2016-Galil Medical to be acquired by BTG plc
in Q2 2016
4 December 2014 - UK-based specialist healthcare company BTG Plc
said that it has entered into an agreement to acquire US-based interventional pulmonology business PneumRx Inc on a debt free cash free basis for an initial cash consideration of USD 230m (approximately GBP 1471m) and up to USD 245m (approximately GBP 1561m ) in performance-related future milestone payments.
BTG International Inc is the US subsidiary of UK's BTG Plc
17 September 2013 - Belgian implantable medical devices specialist Eckert & Ziegler Bebig SA (EBR:EZBG) said today that it had agreed to purchase the US-based brachytherapy business of Biocompatibles Inc, part of UK specialist healthcare firm BTG plc
7 December 2011 - British BTG plc
(LSE:BGC) Wednesday said it had licensed to Japanese Ohara Pharmaceutical Co Ltd the rights to Voraxaze (glucarpidase), an experimental treatment for the rapid and sustained reduction of toxic methotrexate (MTX) levels caused by impaired renal function.
Companies Mentioned in this Report: BTG Plc
, ZonMw, Smerud Medical Research International AS, Cumberland Pharmaceuticals, Inc.
15 July 2013 - UK specialist healthcare firm BTG plc
(LON:BTG) on Monday said it had completed its USD200m (EUR153.